Recent studies have shown that HSPA5 interacts with and maintains the stability of GPX4 and inhibits ferroptosis in CRC cells, providing a new target for the prognosis and treatment of CRC patients (76). This evidence concerns the gene HSPA5 and colorectal carcinoma.